Andere talen Evolent Health, Inc.

Aandelen

EVH

US30050B1017

Geschatte realtime Cboe BZX Andere beurzen 19:52:45 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
29,82 ^USD	+0,62%		-2,10%	-9,51%

28/03	EVOLENT HEALTH, INC. : Canaccord Genuity ontvangt een koopadvies	ZM
15/03	EVOLENT HEALTH, INC. : JPMorgan Chase geeft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	22/02
Evolent Health: Q4 Earnings Snapshot	22/02
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	22/02
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	22/02
Evolent Announces Fourth Quarter and Full Year 2023 Results	22/02
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	22/02
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors	14/02
Evolent Health, Inc. Announces Board Changes	14/02
Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024	25/01
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan	06/12
Evolent Health Plans $350 Million Convertible Senior Notes Offering; Shares Fall	05/12
Evolent Health Shares Drop on $350 Million Note Offering	05/12
Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan	05/12
Evolent Health : INDEPENDENT AUDITORS’ REPORT - Form 8-K	03/11
Evolent Health: Q3 Earnings Snapshot	02/11
Earnings Flash (EVH) EVOLENT HEALTH Posts Q3 EPS $0.30	02/11
Earnings Flash (EVH) EVOLENT HEALTH Reports Q3 Revenue $511M, vs. Street Est of $509.8M	02/11
Evolent Announces Third Quarter 2023 Results	02/11
Evolent Health, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2023 and Full Year 2023	02/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Evolent Health, Inc.

Aandelen

EVH

US30050B1017

Andere talen

Filters